BLS — BLS Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$255.28m
- AU$250.42m
- AU$74.23m
Annual cashflow statement for BLS Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
R2022 June 30th | C2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0 | 0.076 | 0.031 | 0 | 0.068 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.507 | -1.13 | -3.56 | 6.28 | 5.41 |
| Capital Expenditures | -0.06 | -0.059 | -0.493 | -2.07 | -3.81 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.087 | 4.16 | 0 | — | — |
| Sale of Business | |||||
| Cash from Investing Activities | 0.027 | 4.1 | -0.493 | -2.07 | -3.55 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.493 | 0.805 | 1.21 | 2.42 | 3.76 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.005 | 3.78 | -2.82 | 6.64 | — |